GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sirio Pharma Co Ltd (SZSE:300791) » Definitions » Interest Income

Sirio Pharma Co (SZSE:300791) Interest Income : ¥7 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Sirio Pharma Co Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Sirio Pharma Co's interest income for the three months ended in Mar. 2025 was ¥2 Mil. Its interest income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥7 Mil.

Sirio Pharma Co Interest Income Historical Data

The historical data trend for Sirio Pharma Co's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirio Pharma Co Interest Income Chart

Sirio Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.17 6.99 11.58 7.02 6.89

Sirio Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 2.00 1.46 2.03 1.99

Sirio Pharma Co Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sirio Pharma Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sirio Pharma Co Ltd (SZSE:300791) » Definitions » Interest Income
Comparable Companies
SZSE:002726 SZSE:002650 SHSE:600300 SHSE:605300 SZSE:003000 SZSE:001313 SHSE:600251 SZSE:300973 SHSE:600429 SZSE:002481 XSWX:NESN XPAR:BN KHC SHSE:603288 GIS K NSE:NESTLEIND SHSE:600887 SZSE:300999 LSE:ABF
Traded in Other Exchanges
N/A
Address
No. 83, Taishan Road, Guangdong Province, Shantou, CHN, 515057
Website
http://www.siriopharm.com
Sirio Pharma Co Ltd is engaged in the research and development, production, sales and technical services of nutrition and health food, food production, sales, import and export of goods.
Executives
Chen Qiong Directors, executives
Yao Zhuang Min Directors, executives
Zheng Li Qun Directors, executives
Yang Rui Directors, executives

Sirio Pharma Co Headlines

No Headlines